For a long time, pharmaceutical companies haven’t really needed to focus on patients expressing opinions over treatment. It was the physicians after all who would make key treatment decisions for patients, so pharmaceutical companies could in turn focus their marketing towards the physicians themselves. This was especially true for complex diseases like Parkinson’s. In the present day however, things have changed significantly. Empowered by social media and technology, patients can now have more of a say than ever before when it comes to options for treatment. Patients express opinions on where and how they want to get treated as well as whether they want to get treated at all. They even have the ability to affect the decisions of other patients by sharing their thoughts over social networks and blogs.
The things patients share online offer a multitude of valuable insights for pharmaceutical companies to draw on and improve their communication with patients and physicians alike. Online conversations between patients, doctors and researchers also promote patient education and raise disease awareness. As a consequence of this improvement in education about different diseases patients can better manage their condition.
Through social media monitoring, pharmaceutical companies can gain insight into what is driving patients, improve treatments and patient compliance and in turn, increase the overall effectiveness of their products. Here are the 6 essential steps pharmaceutical companies should take for successful social media monitoring.